A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether OC (oxybutynin and clonidine) oral solution
is effective in reducing saliva secretion in patients suffering from Parkinson's Disease with
excessive salivation.